As of Jul 02
| -0.09 / -3.30%|
The 1 analysts offering 12-month price forecasts for Biocept Inc have a median target of 4.00, with a high estimate of 4.00 and a low estimate of 4.00. The median estimate represents a +51.52% increase from the last price of 2.64.
The current consensus among 1 polled investment analysts is to Buy stock in Biocept Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.